These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7562340)

  • 41. Bone regeneration using rhBMP-2 induction in hemimandibulectomy type defects of elderly sub-human primates.
    Boyne PJ; Salina S; Nakamura A; Audia F; Shabahang S
    Cell Tissue Bank; 2006; 7(1):1-10. PubMed ID: 16511659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pleiotropism of bone morphogenetic proteins: from bone induction to cementogenesis and periodontal ligament regeneration.
    Ripamonti U; Teare J; Petit JC
    J Int Acad Periodontol; 2006 Jan; 8(1):23-32. PubMed ID: 16459886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rats.
    Marden LJ; Hollinger JO; Chaudhari A; Turek T; Schaub RG; Ron E
    J Biomed Mater Res; 1994 Oct; 28(10):1127-38. PubMed ID: 7829543
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus).
    Ripamonti U; Heliotis M; van den Heever B; Reddi AH
    J Periodontal Res; 1994 Nov; 29(6):439-45. PubMed ID: 7877080
    [No Abstract]   [Full Text] [Related]  

  • 46. Non-human primate models for testing the efficacy and safety of periodontal regeneration procedures.
    Caton J; Mota L; Gandini L; Laskaris B
    J Periodontol; 1994 Dec; 65(12):1143-50. PubMed ID: 7877087
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biotechnology and bone graft substitutes.
    Kenley RA; Yim K; Abrams J; Ron E; Turek T; Marden LJ; Hollinger JO
    Pharm Res; 1993 Oct; 10(10):1393-401. PubMed ID: 8272399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The bone morphogenetic protein family: multifunctional cellular regulators in the embryo and adult.
    Wozney JM
    Eur J Oral Sci; 1998 Jan; 106 Suppl 1():160-6. PubMed ID: 9541220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perspectives in the biological function, the technical and therapeutic application of bone morphogenetic proteins.
    Hoffmann A; Weich HA; Gross G; Hillmann G
    Appl Microbiol Biotechnol; 2001 Oct; 57(3):294-308. PubMed ID: 11759676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant bone morphogenetic proteins: novel substances for enhancing bone healing.
    Kirker-Head CA
    Vet Surg; 1995; 24(5):408-19. PubMed ID: 8585149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Healing of experimentally created defects: a review.
    Aaboe M; Pinholt EM; Hjørting-Hansen E
    Br J Oral Maxillofac Surg; 1995 Oct; 33(5):312-8. PubMed ID: 8555150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dental benefit found during orthopedic study.
    J Am Dent Assoc; 1996 Jul; 127(7):854. PubMed ID: 8754459
    [No Abstract]   [Full Text] [Related]  

  • 53. Is prolonged stimulation of bone growth a therapeutic possibility?
    Mundy GR
    Mol Cell Endocrinol; 1991 Feb; 75(2):C19-25. PubMed ID: 2050268
    [No Abstract]   [Full Text] [Related]  

  • 54. Growth factors influencing bone development.
    Wozney JM; Rosen V; Byrne M; Celeste AJ; Moutsatsos I; Wang EA
    J Cell Sci Suppl; 1990; 13():149-56. PubMed ID: 2084114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Osteoinduction and -reparation].
    Kübler NR
    Mund Kiefer Gesichtschir; 1997 Feb; 1(1):2-25. PubMed ID: 9483923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Osteoinduction by demineralised bone.
    Solheim E
    Int Orthop; 1998; 22(5):335-42. PubMed ID: 9914941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel agents that promote bone regeneration.
    Schaub RG; Wozney J
    Curr Opin Biotechnol; 1991 Dec; 2(6):868-71. PubMed ID: 1367961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microfluidic fabrication of microcarriers with sequential delivery of VEGF and BMP-2 for bone regeneration.
    Dashtimoghadam E; Fahimipour F; Tongas N; Tayebi L
    Sci Rep; 2020 Jul; 10(1):11764. PubMed ID: 32678204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of age on biomaterial-mediated in situ bone tissue regeneration.
    Liu M; Nakasaki M; Shih YV; Varghese S
    Acta Biomater; 2018 Sep; 78():329-340. PubMed ID: 29966759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of rhBMP-2 and PRP delivery by biodegradable β-tricalcium phosphate scaffolds on new bone formation in a non-through rabbit cranial defect model.
    Lim HP; Mercado-Pagan AE; Yun KD; Kang SS; Choi TH; Bishop J; Koh JT; Maloney W; Lee KM; Yang YP; Park SW
    J Mater Sci Mater Med; 2013 Aug; 24(8):1895-903. PubMed ID: 23779152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.